TipRanks
Huron Consulting (DE:HUR)
FRANKFURT:HUR
Germany Market
EarningsQ2 2026 Earnings Report

Huron Consulting (HUR) Q2 2026 Earnings Report

2 Followers

DE:HUR Q2 2026 EPS Results

Actual EPS€2.20
Consensus EPS€1.94
Beat/MissBeat by +€0.26
One Year Ago EPS€1.69

DE:HUR Q2 2026 Revenue Results

Actual Revenue€423.93M
Expected Revenue€400.67M
Beat/MissBeat by +€23.26M
YoY Revenue Growth+15.37%

Earnings Announcement Details

QuarterQ2 2026
Date07/28/2026
TimeAfter Close
Conference CallTuesday, July 28, 2026
DE:HUR Upcoming Earnings
Huron Consulting's next earnings date is estimated for November 3, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:HUR Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 28, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong positive operational and financial momentum: record RBR, robust organic growth, significant adjusted EPS growth (+30% adjusted EPS YoY), margin expansion, strong free cash flow, raised guidance, and accelerating AI-driven digital bookings and managed services. Areas of caution include higher unallocated corporate expenses, a less favorable effective tax rate, leverage that remains above the target range (though improving), and near-term capacity/hiring needs driven by elevated utilization. On balance the positives materially outweigh the challenges.
Company Guidance
Huron raised and narrowed full-year RBR guidance to $1.85B–$1.89B (≈+12% at the midpoint vs. 2025), maintained adjusted EBITDA margin guidance of 14.5%–15.0% of RBR (≈+50 bps vs. 2025 midpoint) and increased adjusted non‑GAAP EPS to $9.00–$9.40 (≈+17% at the midpoint vs. 2025); free cash flow is expected to be $180M–$220M (net of cash taxes and interest, excl. noncash stock comp) with free cash flow per share at about $12 at the midpoint (≈10% yield at a $120 share price). Management expects RelateCare to add ~$30M of 2026 RBR and be ~+$0.10 accretive to 2026 adjusted EPS, and reiterated segment targets of Healthcare RBR mid‑teen growth with ~30%–32% operating margins, Education RBR mid‑ to upper‑single‑digit growth with 24%–26% margins, and Commercial RBR low‑teen growth with 19%–21% margins; unallocated corporate expenses (ex. restructuring and deferred comp) are expected to rise low‑double‑digits vs. 2025, full‑year diluted shares are guided to ~16.6–16.8M, and the company reiterated its leverage target of 2.0x–2.5x by year‑end (vs. 2.8x adj. EBITDA as of 6/30/26).
Record RBR and Revenue Growth
Record revenues before reimbursable expenses (RBR) of $465.6M in Q2 2026, up 15.7% year-over-year (from $402.5M) with 10.8% organic RBR growth in the quarter.
Raised Full-Year Guidance
Updated full-year RBR guidance increased and narrowed to $1.85B–$1.89B, representing ~12% growth at the midpoint versus 2025; adjusted non-GAAP EPS guidance increased to $9.00–$9.40, ~17% growth at the midpoint.
Margin Expansion and Profitability
Adjusted EBITDA of $72.6M in Q2 2026 (15.6% of RBR) vs $60.6M (15.1% of RBR) in Q2 2025, reflecting continued margin expansion; adjusted net income (adjusted EPS) of $40.2M or $2.46 per diluted share, up 30.2% year-over-year.
Strong Net Income and EPS
GAAP net income of $31.2M or $1.91 per diluted share in Q2 2026 versus $19.4M or $1.09 in Q2 2025; net income margin increased to 6.6% from 4.7%.
Robust Free Cash Flow and Cash From Ops
Operating cash flow of $120.5M and free cash flow of $111.3M in Q2 2026 versus operating cash flow of $80.1M in prior-year quarter; full-year free cash flow guidance $180M–$220M, midpoint implying ~ $12 free cash flow per share.
Bookings and Digital Momentum
First-half digital bookings increased >20% year-over-year; digital capability RBR grew 9% in Q2 2026 (year-over-year and sequential); >60% of digital bookings in H1 2026 included direct AI scope or AI-enabled delivery (up from ~35% in H1 2025).
Managed Services Acceleration
Healthcare managed services RBR grew 64% in Q2 2026 vs Q2 2025, including 43% organic growth; strong client retention and outcomes-based pricing driving recurring revenue and higher margins.
Segment Performance — Healthcare, Education, Commercial
Healthcare RBR $232.3M, up 17.4% YoY (50% of company RBR); Education RBR $139.4M, up 7.8% YoY (30% of company RBR) with operating margin improvement to 26.8% from 25%; Commercial RBR $94.0M, up 24.6% YoY (12.2% organic excluding acquisitions) with operating margin improvement to 21% from 16.6%.
Accretive M&A and Strategic Additions
Acquisition of RelateCare expected to add ~ $30M of RBR in 2026 and be accretive to 2026 adjusted EPS by approximately $0.10; acquisitions also contributed incremental RBR in the quarter from Treliant, Wilson Perumal, Eclipse Insights and Axiom.
Capital Allocation and Share Repurchases
Q2 2026 share repurchases of ~$53.1M (~438k shares); YTD repurchases ~$208.6M (~1.6M shares, ~9% of outstanding shares at the start of the year); net debt decreased sequentially and leverage improved to 2.8x adjusted EBITDA from 3.1x at Q1.

DE:HUR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 03, 2026
2026 (Q3)
2.21 / -
1.874―
2026 (Q2)
1.94 / 2.20
1.68730.16% (+0.51)
2026 (Q1)
1.43 / 1.54
1.4992.98% (+0.04)
2025 (Q4)
1.74 / 1.94
1.69614.21% (+0.24)
2025 (Q3)
1.76 / 1.87
1.49925.00% (+0.37)
2025 (Q2)
1.60 / 1.69
1.49912.50% (+0.19)
2025 (Q1)
1.03 / 1.50
1.09836.59% (+0.40)
2024 (Q4)
1.36 / 1.70
1.15147.29% (+0.54)
2024 (Q3)
1.44 / 1.50
1.2420.86% (+0.26)
2024 (Q2)
1.37 / 1.50
1.23221.74% (+0.27)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed